Directing human embryonic stem cell differentiation by non-viral delivery of siRNA in 3D culture
Open accessAbstract
Human embryonic stem cells (hESCs) hold great potential as a resource for regenerative medicine. Before achieving therapeutic relevancy, methods must be developed to control stem cell differentiation. It is clear that stem cells can respond to genetic signals, such as those imparted by nucleic acids, to promote lineage-specific differentiation. Here we have developed an efficient system for delivering siRNA to hESCs in a 3D culture matrix using lipid-like materials. We show that non-viral siRNA delivery in a 3D scaffolds can efficiently knockdown 90% of GFP expression in GFP-hESCs. We further show that this system can be used as a platform for directing hESC differentiation. Through siRNA silencing of the KDR receptor gene, we achieve concurrent downregulation (60-90%) in genes representative of the endoderm germ layer and significant upregulation of genes representative of the mesoderm germ layer (27-90 fold). This demonstrates that siRNA can direct stem cell differentiation by blocking genes representative of one germ layer and also provides a particularly powerful means to isolate the endoderm germ layer from the mesoderm and ectoderm. This ability to inhibit endoderm germ layer differentiation could allow for improved control over hESC differentiation to desired cell types.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Gene-activated matrices maintain permanent transfection with 60-90% siRNA-mediated gene knock-down during 3D organoid development but do not allow transfection at different time points.
“While this system maintains a permanent transfection with 60–90% of siRNA-mediated gene knock-down during 3D organoid development, it does not allow transfection at different time points.”
From Direct transfection of clonal organoids in Matrigel microbeads: a promising approach toward organoid-based genetic screens (2018) · cites this paper as [18]
The Introduction reports 60–90% silencing in a 3D hESC matrix, and the Results report siRNA-mediated knockdown during differentiation. But the Results describe knockdown measured after three days, not permanent transfection or 3D organoid development. The paper does not establish that transfection cannot occur at different time points. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 43
- [1]Keller G Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes Dev 2005 19 10 1129 55 15905405
- [2]Wobus AM Boheler KR Embryonic stem cells: prospects for developmental biology and cell therapy Physiol Rev 2005 85 2 635 78 15788707
- [3]Keller R Davidson LA Shook DR How we are shaped: the biomechanics of gastrulation Differentiation 2003 71 3 171 205 12694202
- [4]Zoldan J Kraehenbuehl PT Lytton-Jean AKR Langer RS Anderson DG Stein GS Borowski M Luong MX Shi M-J Smith KP Vasquex P Tissue Engineering for Stem Cell Mediated Regenerative Medicine Human Stem Cell Technology & Biology New Jersey John Wiley & Sons, Inc 2010 377 399
- [5]Hay DC Sutherland L Clark J Burdon T Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells Stem Cells 2004 22 2 225 35 14990861
- [6]Babaie Y Herwig R Greber B Brink TC Wruck W Groth D Lehrach H Burdon T Adjaye J Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells Stem Cells 2007 25 2 500 10 17068183
- [7]Guo S Huang Y Jiang Q Sun Y Deng L Liang Z Du Q Xing J Zhao Y Wang PC Dong A Liang XJ Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte ACS Nano 2010 4 9 5505 11 20707386 PMC3044603
- [8]Matin MM Walsh JR Gokhale PJ Draper JS Bahrami AR Morton I Moore HD Andrews PW Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells Stem Cells 2004 22 5 659 68 15342930
- [9]Greber B Lehrach H Adjaye J Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal BMC Dev Biol 2007 7 46 17506876 PMC1885259
- [10]Zaehres H Lensch MW Daheron L Stewart SA Itskovitz-Eldor J Daley GQ High-efficiency RNA interference in human embryonic stem cells Stem Cells 2005 23 3 299 305 15749924
- [11]Rodriguez RT Velkey JM Lutzko C Seerke R Kohn DB O'Shea KS Firpo MT Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types Exp Biol Med (Maywood) 2007 232 10 1368 80 17959850
- [12]Eguchi A Meade BR Chang YC Fredrickson CT Willert K Puri N Dowdy SF Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat Biotechnol 2009 27 6 567 71 19448630 PMC2694965
- [13]Hyslop L Stojkovic M Armstrong L Walter T Stojkovic P Przyborski S Herbert M Murdoch A Strachan T Lako M Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages Stem Cells 2005 23 8 1035 43 15983365
- [14]Braam SR Denning C van den Brink S Kats P Hochstenbach R Passier R Mummery CL Improved genetic manipulation of human embryonic stem cells Nat Methods 2008 5 5 389 92 18391958
- [15]Hohenstein KA Pyle AD Chern JY Lock LF Donovan PJ Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells Stem Cells 2008 26 6 1436 43 18323409 PMC3882114
- [16]Burdick JA Vunjak-Novakovic G Engineered microenvironments for controlled stem cell differentiation Tissue Eng Part A 2009 15 2 205 19 18694293 PMC2716398
- [17]Griffith LG Swartz MA Capturing complex 3D tissue physiology in vitro Nat Rev Mol Cell Biol 2006 7 3 211 24 16496023
- [18]Zoldan J Levenberg S Engineering three-dimensional tissue structures using stem cells Methods Enzymol 2006 420 381 91 17161707
- [19]Akinc A Zumbuehl A Goldberg M Leshchiner ES Busini V Hossain N Bacallado SA Nguyen DN Fuller J Alvarez R Borodovsky A Borland T Constien R de Fougerolles A Dorkin JR Narayanannair Jayaprakash K Jayaraman M John M Koteliansky V Manoharan M Nechev L Qin J Racie T Raitcheva D Rajeev KG Sah DW Soutschek J Toudjarska I Vornlocher HP Zimmermann TS Langer R Anderson DG A combinatorial library of lipid-like materials for delivery of RNAi therapeutics Nat Biotechnol 2008 26 5 561 9 18438401 PMC3014085
- [20]Nikolsky Y Nikolskaya T Bugrim A Biological networks and analysis of experimental data in drug discovery Drug Discov Today 2005 10 9 653 62 15894230
- [21]Shannon P Markiel A Ozier O Baliga NS Wang JT Ramage D Amin N Schwikowski B Ideker T Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res 2003 13 11 2498 504 14597658 PMC403769
- [22]Strulovici Y Leopold PL O'Connor TP Pergolizzi RG Crystal RG Human embryonic stem cells and gene therapy Mol Ther 2007 15 5 850 66 17356540
- [23]Levenberg S Zoldan J Basevitch Y Langer R Endothelial potential of human embryonic stem cells Blood 2007 110 3 806 14 17412888 PMC1924772
- [24]Ruoslahti E RGD and other recognition sequences for integrins Annu Rev Cell Dev Biol 1996 12 697 715 8970741
- [25]Buck CA Horwitz AF Cell surface receptors for extracellular matrix molecules Annu Rev Cell Biol 1987 3 179 205 2825736
- [26]Houseman BT Mrksich M The microenvironment of immobilized Arg-Gly-Asp peptides is an important determinant of cell adhesion Biomaterials 2001 22 9 943 55 11311013
- [27]Wilson NK Foster SD Wang X Knezevic K Schutte J Kaimakis P Chilarska PM Kinston S Ouwehand WH Dzierzak E Pimanda JE de Bruijn MF Gottgens B Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators Cell Stem Cell 2010 7 4 532 44 20887958
- [28]Kim J Woo AJ Chu J Snow JW Fujiwara Y Kim CG Cantor AB Orkin SH A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs Cell 2010 143 2 313 24 20946988 PMC3018841
- [29]Sun M Yang L Feldman RI Sun XM Bhalla KN Jove R Nicosia SV Cheng JQ Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src J Biol Chem 2003 278 44 42992 3000 12933816
- [30]Kang HY Huang HY Hsieh CY Li CF Shyr CR Tsai MY Chang C Chuang YC Huang KE Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer J Bone Miner Res 2009 24 7 1180 93 19257827
- [31]Cantley LC The phosphoinositide 3-kinase pathway Science 2002 296 5573 1655 7 12040186
- [32]McLean AB D'Amour KA Jones KL Krishnamoorthy M Kulik MJ Reynolds DM Sheppard AM Liu H Xu Y Baetge EE Dalton S Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed Stem Cells 2007 25 1 29 38 17204604
- [33]Carmeliet P Mechanisms of angiogenesis and arteriogenesis Nat Med 2000 6 4 389 95 10742145
- [34]Olsson AK Dimberg A Kreuger J Claesson-Welsh L VEGF receptor signalling - in control of vascular function Nat Rev Mol Cell Biol 2006 7 5 359 71 16633338
- [35]Holmes K Roberts OL Thomas AM Cross MJ Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition Cell Signal 2007 19 10 2003 12 17658244
- [36]Eichmann A Yuan L Moyon D Lenoble F Pardanaud L Breant C Vascular development: from precursor cells to branched arterial and venous networks Int J Dev Biol 2005 49 2–3 259 67 15906240
- [37]Yancopoulos GD Davis S Gale NW Rudge JS Wiegand SJ Holash J Vascular-specific growth factors and blood vessel formation Nature 2000 407 6801 242 8 11001067
- [38]Shalaby F Rossant J Yamaguchi TP Gertsenstein M Wu XF Breitman ML Schuh AC Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 1995 376 6535 62 6 7596435
- [39]Ober EA Olofsson B Makinen T Jin SW Shoji W Koh GY Alitalo K Stainier DY Vegfc is required for vascular development and endoderm morphogenesis in zebrafish EMBO Rep 2004 5 1 78 84 14710191 PMC1298958
- [40]Lammert E Cleaver O Melton D Induction of pancreatic differentiation by signals from blood vessels Science 2001 294 5542 564 7 11577200
- [41]Matsumoto K Yoshitomi H Rossant J Zaret KS Liver organogenesis promoted by endothelial cells prior to vascular function Science 2001 294 5542 559 63 11577199
- [42]Cleaver O Melton DA Endothelial signaling during development Nat Med 2003 9 6 661 8 12778164
- [43]Lammert E Cleaver O Melton D Role of endothelial cells in early pancreas and liver development Mech Dev 2003 120 1 59 64 12490296
Cited by
Sorted by citations
Laperrousaz, B., Porte, S., Gerbaud, S., Härmä, V., Kermarrec, F., Hourtane, V., Bottausci, F., Gidrol, X., & Picollet-D’hahan, N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky030 · Cited by 54 · see citing works
“Gene-activated matrices that combine scaffolds or hydrogels and lipid-based gene delivery reagents were developed to allow direct in situ transfection of cells that grow in 3D matrices (18,19).”
BackgroundOptimized delivery of siRNA into 3D tumor spheroid cultures in situ
Morgan, R. G., Chambers, A. C., Legge, D. N., Coles, S. J., Greenhough, A., & Williams, A. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-26253-3 · Cited by 47 · see citing works
Combining Topographical and Genetic Cues to Promote Neuronal Fate Specification in Stem Cells
Purcell, E. K., Naim, Y., Yang, A., Leach, M. K., Velkey, J. M., Duncan, R. K., & Corey, J. M. (2012) · Biomacromolecules · doi:10.1021/bm301220k · Cited by 26 · see citing works
- Authors
- Zoldan, J., Lytton-Jean, A. K. R., Karagiannis, E. D., Deiorio-Haggar, K., Bellan, L. M., Langer, R., & Anderson, D. G.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Massachusetts Institute of Technology (US)
- Harvard–MIT Division of Health Sciences and Technology (US)
- Corresponding author
- Anderson, Daniel G.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 32
- Issue
- 31
- Pages
- 7793-7800
- ISSN
- 0142-9612 (ISSN-L)
- PMC
- PMC3313656
- OpenAlex
- W1996740541
- Cited by
- 47
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 5
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- Alnylam Pharmaceuticals
- National Institutes of Health (5r01de016516-10, 4r37eb000244-34, EB-000244)
- National Institute of Biomedical Imaging and Bioengineering (EB-000244, R01EB000244, R37-EB000244)
- National Institute of Dental and Craniofacial Research (R01-DE016516, DE016561)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, siRNA delivery, non-viral gene delivery, 3D cell culture, stem cell differentiation, germ layer specification, endoderm differentiation, mesoderm differentiation, KDR receptor, gene silencing, regenerative medicine
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Humans, Viruses, Gene Transfer Techniques, Cell Culture Techniques, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Green Fluorescent Proteins, Mice, Embryonic Stem Cells, Gene Knockdown Techniques, Embryoid Bodies, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review